You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma, Renal Cell

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Danshen Injection for Acute Kidney Injury in Primary Nephrotic

Completed
  • Acute Kidney Injury
  • +2 more
  • Wenzhou, Zhejiang, China
    The First Affiliated Hospital of Wenzhou Medical University
Oct 6, 2023

Acute Myeloid Leukemia Trial in Chicago (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Chicago, Illinois
    Northwestern University
Feb 16, 2023

Intestinal GVHD Trial in Rome (shear wave elastography)

Recruiting
  • Intestinal GVHD
  • shear wave elastography
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli
Mar 27, 2023

Enterovirus 71 Inactivated Vaccine Combined Immunization in

Recruiting
  • Hand, Foot and Mouth Disease
  • EV71 Inactivated Vaccine
  • Baoshan, Shanghai, China
  • +5 more
Jul 7, 2022

Acute Kidney Injury, Probiotics, Sepsis Trial in Guadalajara (Probiotics, Placebo)

Recruiting
  • Acute Kidney Injury
  • +2 more
  • Probiotics
  • Placebo
  • Guadalajara, Jalisco, Mexico
    HCG
Aug 24, 2021

Hepatocellular Carcinoma Trial in France (TACE, TACE+ RTC)

Completed
  • Hepatocellular Carcinoma
  • TACE
  • TACE+ RTC
  • Amiens, France
  • +17 more
Dec 23, 2021

Recurrent Histiocytic and Dendritic Cell Tumor, Recurrent Non-Hodgkin Lymphoma, Refractory Histiocytic and Dendritic Cell Tumor

Recruiting
  • Recurrent Histiocytic and Dendritic Cell Neoplasm
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Dec 5, 2022

Prostate Cancer Trial in Worldwide (Relugolix, Leuprolide Acetate)

Completed
Has Results
  • Prostate Cancer
  • Tucson, Arizona
  • +161 more
Jan 6, 2022

B-cell Lymphoma Trial in Xuzhou (ASCT+CAR-T Cell Infusion)

Recruiting
  • B-cell Lymphoma
  • ASCT+CAR-T Cell Infusion
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023

Respiratory Viral Infection, SARS CoV 2 Infection Trial in Banjul

Active, not recruiting
  • Respiratory Viral Infection
  • SARS CoV 2 Infection
    • Banjul, Western Region, Gambia
      Field study in the West Coast Region and Kanifing Municipality C
    Jul 11, 2023

    Clinical Treatments for Patients With Oropharyngeal Carcinoma

    Recruiting
    • Oropharynx Carcinoma
    • Surgery for early-stage OPC
    • +4 more
    • Shanghai, Shanghai, China
      Department of Otorhinolaryngology, Eye & ENT Hospital
    Apr 18, 2022

    DLBCL Trial (Acalabrutinib, Rituximab)

    Not yet recruiting
    • Diffuse Large B-Cell Lymphoma
    • (no location specified)
    Jul 11, 2023

    Actinic Keratosis, Squamous Cell Carcinoma Trial in Worldwide (ingenol disoxate gel 0.018%, ingenol disoxate gel 0.037%, Vehicle

    Terminated
    Has Results
    • Actinic Keratosis
    • Squamous Cell Carcinoma
    • ingenol disoxate gel 0.018%
    • +2 more
    • Hot Springs, Arkansas
    • +58 more
    Oct 8, 2019

    Carotid Stenosis Trial in Chengdu (administering RASI (the trade name or universal name will not be stipulated) before stenting,

    Not yet recruiting
    • Carotid Stenosis
    • administering RASI (the trade name or universal name will not be stipulated) before stenting
    • administering CCB (the trade name or universal name will not be stipulated) before stenting
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Jun 7, 2023

    Hematological Malignancies Trial in Boston, Durham (Pasireotide)

    Completed
    Has Results
    • Hematological Malignancies
    • Boston, Massachusetts
    • +1 more
    Oct 19, 2021

    Complex Perianal Fistulas Trial in Changsha (Human TH-SC01 Cell Injection, Saline solution)

    Not yet recruiting
    • Complex Perianal Fistulas
    • Human TH-SC01 Cell Injection
    • Saline solution
    • Changsha, Hunan, China
      Xiangya Hospital Central University
    Dec 28, 2022

    Multiple Myeloma, Plasma Cell Leukemia Trial in Suzhou (CT0594CP)

    Recruiting
    • Multiple Myeloma
    • Plasma Cell Leukemia
    • CT0594CP
    • Suzhou, Jiangsu, China
      First Affiliated Hospital, Soochow University
    Apr 18, 2023

    NSCLC Trial in Rochester (Tetrathiomolybdate)

    Completed
    • Non-Small Cell Lung Cancer
    • Rochester, New York
      University of Rochester
    Jul 17, 2019

    PDAC Trial in Beijing (68Ga-FAPI Positron Emission Tomography-Computed Tomography)

    Recruiting
    • PDAC
    • 68Ga-FAPI Positron Emission Tomography-Computed Tomography
    • Beijing, Beijing, China
      Peking Union Medical College Hospita
    Mar 2, 2022

    Lymphoblastic Leukemia, Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia in Children Trial in Singapore (Phase

    Recruiting
    • Lymphoblastic Leukemia
    • +4 more
    • Phase I
    • Phase II
    • Singapore, Singapore
      KK Women's and Children's hospital
    Jun 20, 2022

    Chronic Lymphocytic Leukemia Trial in Portland (drug, procedure, biological, other)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jul 12, 2023

    T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma Trial in Chicago (Fenretinide)

    Not yet recruiting
    • T-cell Lymphoma
    • +10 more
    • Chicago, Illinois
      Rush University Medical Center
    Oct 24, 2022

    Kidney Transplantation Trial in Boston (aldesleukin)

    Terminated
    Has Results
    • Kidney Transplantation
    • aldesleukin
    • Boston, Massachusetts
      Anil Chandraker
    Jun 23, 2021

    Hematopoietic Stem Cell Transplant Trial in Ann Arbor (Cardio-oncology program)

    Not yet recruiting
    • Hematopoietic Stem Cell Transplant
    • Cardio-oncology program
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Jul 6, 2023

    Tumors Trial in France (Blood and tumor samples)

    Recruiting
    • Neoplasms
    • Blood and tumor samples
    • Annecy, France
    • +5 more
    Apr 8, 2022